AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BIOXYNE LTD

0.057

+0.0047.55%

Volume:5.09M

Turnover:281.26K

Market Cap:129.35M

PE:14.29

High:0.058

Open:0.053

Low:0.053

Close:0.053

52wk High:0.062

52wk Low:0.020

Shares:2.27B

Float Shares:595.07M

Volume Ratio:1.09

T/O Rate:0.85%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.004

EPS(LYR):0.002

ROE:66.14%

ROA:24.99%

PB:6.41

PE(LYR):24.78

Loading ...

Overview Company News Filings

Why Investors Shouldn't Be Surprised By Bioxyne Limited's (ASX:BXN) 30% Share Price Surge

Simply Wall St.

Bioxyne Secures Initial Purchase Orders for Psychedelic Drug; Shares Rise 7%

MT Newswires Live

BRIEF-Bioxyne Commercialises GMP-Manufactured Psilocybin Capsules

Bioxyne Ltd - Commercialises Gmp-Manufactured Psilocybin Capsules

THOMSON REUTERS

BRIEF-Bioxyne Reports Qtrly Revenue A$17.2 Mln

Bioxyne Ltd - Reports a$17.2 Mln Quarterly Revenue

THOMSON REUTERS

The 11% return this week takes Bioxyne's (ASX:BXN) shareholders five-year gains to 215%

Simply Wall St.

Bioxyne Enters Costa Rica, Panama Medicinal Cannabis Markets with Manufacturing, Supply Agreement with Remidose; Shares Rise 3%

MT Newswires Live

BRIEF-Bioxyne's Unit Enters Manufacturing Agreement With Remidose Latam Srl

Bioxyne - Under Deal, Bls to Manufacture Thc Pastille Products for Supply Into Medicinal Cannabis Markets of Costa Rica & Panama

THOMSON REUTERS

Bioxyne Ltd - Unit Entered Manufacturing Agreement With Remidose Latam Srl

THOMSON REUTERS

Bioxyne Names Chief Financial Officer of Unit, Shares Fall 5%

MT Newswires Live

Bioxyne Ltd-Bxn Strengthens Financial Leadership - Key CFO Appointment

THOMSON REUTERS

Bioxyne Unit Ships Second GMP MDMA Batch to Victoria

MT Newswires Live

Bioxyne Executed Exclusive Import, Manufacture And Supply Agreement With Curaleaf International For Australia

Bioxyne Limited's (ASX:BXN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.

Bioxyne's Unit Receives AU$1.7 Million Funding for UK Medical Cannabis Facility; Shares Fall 5%

MT Newswires Live

Bioxyne Unit Fulfills Two Purchase Orders for MDMA Capsules in Australia

MT Newswires Live

Bioxyne Signs Manufacture, Supply Deal with Cannabis Company; Shares Down 3%

MT Newswires Live

BRIEF-Bioxyne Executed Exclusive Import, Manufacture And Supply Agreement With Curaleaf International For Australia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BXN.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BXN.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BXN.AU\",,,,,undefined,":{"symbol":"BXN.AU","market":"AU","secType":"STK","nameCN":"BIOXYNE LTD","latestPrice":0.057,"timestamp":1774501920000,"preClose":0.053,"halted":0,"volume":5085438,"delay":0,"changeRate":0.07547169811320761,"nameEN":"BIOXYNE LTD","floatShares":595070503,"shares":2269326513,"eps":0.003988,"marketStatus":"Not Yet Opened","change":0.004,"latestTime":"03-26 16:12:00 AEDT","open":0.053,"high":0.058,"low":0.053,"amount":281258,"amplitude":0.09434,"askPrice":0.058,"askSize":1647826,"bidPrice":0.057,"bidSize":229167,"shortable":3,"etf":0,"ttmEps":0.003988,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1774566000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.053,"openAndCloseTimeList":[[1774479600000,1774501200000]],"volumeRatio":1.094048,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BXN.AU","preClose":0.053,"auctionPrice":0.057,"auctionVolume":560467,"auction":3,"marketStatus":"盘后竞价","timestamp":1774501800692}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BXN.AU\",,,,,undefined,":{"symbol":"BXN.AU","floatShares":595070503,"roa":"24.99%","roe":"66.14%","lyrEps":0.0023,"volumeRatio":1.094048,"shares":2269326513,"dividePrice":0,"high":0.058,"amplitude":0.09434,"preClose":0.053,"low":0.053,"week52Low":0.02,"pbRate":"6.41","psRate":"2.70","week52High":0.062,"institutionHeld":0,"latestPrice":0.057,"committee":-0.755815,"eps":0.003988,"divideRate":0,"volume":5085438,"delay":0,"ttmEps":0.003988,"open":0.053,"prevYearClose":0.042,"prevWeekClose":0.051,"prevMonthClose":0.06,"prevQuarterClose":0.042,"fiveDayClose":0.05,"twentyDayClose":0.06,"sixtyDayClose":0.042},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BXN.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-25","symbol":"BXN.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771974000000,"name":null,"time":"","dateTimestamp":1771938000000,"actualEps":null},{"date":"2025-07-28","symbol":"BXN.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753660800000,"name":null,"time":"","dateTimestamp":1753624800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BXN.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BXN.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2611319193","title":"Why Investors Shouldn't Be Surprised By Bioxyne Limited's (ASX:BXN) 30% Share Price Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2611319193","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611319193?lang=en_us&edition=fundamental","pubTime":"2026-02-14 04:58","pubTimestamp":1771016315,"startTime":"0","endTime":"0","summary":"Bioxyne Limited ( ASX:BXN ) shares have had a really impressive month, gaining 30% after a shaky period beforehand...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/household/asx-bxn/bioxyne-shares/news/why-investors-shouldnt-be-surprised-by-bioxyne-limiteds-asxb","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/household/asx-bxn/bioxyne-shares/news/why-investors-shouldnt-be-surprised-by-bioxyne-limiteds-asxb","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK7508","BK4211","BK7111","BXN.AU"],"gpt_icon":0},{"id":"2610606323","title":"Bioxyne Secures Initial Purchase Orders for Psychedelic Drug; Shares Rise 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610606323","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610606323?lang=en_us&edition=fundamental","pubTime":"2026-02-11 10:00","pubTimestamp":1770775250,"startTime":"0","endTime":"0","summary":"Bioxyne  secured initial purchase orders for the supply of psilocybin capsules, or BLSPSIL25, through its wholly-owned unit Breathe Life Sciences, according to a Wednesday Australian bourse filing.The capsules are intended for investigational use in treatment-resistant depression and exploratory research into other mental health conditions in Australia, including anxiety disorders, substance use disorders, and post-traumatic stress disorder.These initial orders involve the supply of 250 doses of BLSPSIL25 to authorized prescribers in Queensland and Western Australia, supporting treatment for around 60 patients over the next 12 months.Bioxyne's shares rose nearly 7% in recent trading on Wednesday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","BK7111","BXN.AU","XAO.AU","XKO.AU","BK7508"],"gpt_icon":0},{"id":"2610605317","title":"BRIEF-Bioxyne Commercialises GMP-Manufactured Psilocybin Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2610605317","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610605317?lang=en_us&edition=fundamental","pubTime":"2026-02-11 09:38","pubTimestamp":1770773911,"startTime":"0","endTime":"0","summary":"BRIEF-Bioxyne Commercialises GMP-Manufactured Psilocybin CapsulesFeb 11 (Reuters) - Bioxyne Ltd BXN.AX:COMMERCIALISES GMP-MANUFACTURED PSILOCYBIN CAPSULESFurther company coverage: BXN.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nFWN3Z61EQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BXN.AU","BK7111","BK7508"],"gpt_icon":0},{"id":"2610679384","title":"Bioxyne Ltd - Commercialises Gmp-Manufactured Psilocybin Capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2610679384","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610679384?lang=en_us&edition=fundamental","pubTime":"2026-02-11 05:18","pubTimestamp":1770758331,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z61EQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7111","BXN.AU"],"gpt_icon":0},{"id":"2606757291","title":"BRIEF-Bioxyne Reports Qtrly Revenue A$17.2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2606757291","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606757291?lang=en_us&edition=fundamental","pubTime":"2026-01-28 09:38","pubTimestamp":1769564324,"startTime":"0","endTime":"0","summary":"BRIEF-Bioxyne Reports Qtrly Revenue A$17.2 MlnJan 28 (Reuters) - Bioxyne Ltd BXN.AX:REPORTS A$17.2 MILLION QUARTERLY REVENUEFurther company coverage: BXN.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nFWN3YS0OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7111","BXN.AU"],"gpt_icon":0},{"id":"2606012758","title":"Bioxyne Ltd - Reports a$17.2 Mln Quarterly Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2606012758","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606012758?lang=en_us&edition=fundamental","pubTime":"2026-01-28 05:22","pubTimestamp":1769548945,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260127:nFWN3YS0OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BXN.AU","BK7111"],"gpt_icon":0},{"id":"2605426527","title":"The 11% return this week takes Bioxyne's (ASX:BXN) shareholders five-year gains to 215%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605426527","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605426527?lang=en_us&edition=fundamental","pubTime":"2026-01-23 06:50","pubTimestamp":1769122245,"startTime":"0","endTime":"0","summary":"When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, you can make far...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/household/asx-bxn/bioxyne-shares/news/the-11-return-this-week-takes-bioxynes-asxbxn-shareholders-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/household/asx-bxn/bioxyne-shares/news/the-11-return-this-week-takes-bioxynes-asxbxn-shareholders-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","BXN.AU","BK7111"],"gpt_icon":0},{"id":"2590356926","title":"Bioxyne Enters Costa Rica, Panama Medicinal Cannabis Markets with Manufacturing, Supply Agreement with Remidose; Shares Rise 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590356926","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590356926?lang=en_us&edition=fundamental","pubTime":"2025-12-11 12:56","pubTimestamp":1765428972,"startTime":"0","endTime":"0","summary":"Bioxyne  is set to enter the Costa Rica and Panama medicinal cannabis markets after entering a manufacturing and supply agreement with Remidose LATAM, a Costa Rican entity affiliated with Canadian medicinal cannabis firm, Remidose Aerosols, according to a Thursday filing with the Australian bourse.Bioxyne's wholly-owned subsidiary, Breathe Life Sciences, will manufacture pharmaceutical-grade THC pastille products under the agreement. Supply under the agreement is subject to successful Therapeutic Goods Administration export approvals and relevant in-market product registrations, which the parties will progress immediately.The agreement has an initial 12-month rolling term with automatic renewal. Based on indicative pricing and minimum volumes, the agreement represents potential annual revenue of over AU$1 million once full supply commences, per the filing.Bioxyne's shares rose 3% in recent trading on Thursday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BXN.AU","BK7111"],"gpt_icon":0},{"id":"2590552683","title":"BRIEF-Bioxyne's Unit Enters Manufacturing Agreement With Remidose Latam Srl","url":"https://stock-news.laohu8.com/highlight/detail?id=2590552683","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590552683?lang=en_us&edition=fundamental","pubTime":"2025-12-11 08:53","pubTimestamp":1765414395,"startTime":"0","endTime":"0","summary":"BRIEF-Bioxyne's Unit Enters Manufacturing Agreement With Remidose Latam SrlDec 11  - Bioxyne Ltd BXN.AX:UNIT ENTERED MANUFACTURING AGREEMENT WITH REMIDOSE LATAM SRLUNDER DEAL, BLS TO MANUFACTURE THC PASTILLE PRODUCTS FOR SUPPLY INTO MEDICINAL CANNABIS MARKETS OF COSTA RICA & PANAMAFurther company coverage: BXN.AX ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251211:nFWN3XG14D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","BK7508","BXN.AU"],"gpt_icon":0},{"id":"2590553015","title":"Bioxyne - Under Deal, Bls to Manufacture Thc Pastille Products for Supply Into Medicinal Cannabis Markets of Costa Rica & Panama","url":"https://stock-news.laohu8.com/highlight/detail?id=2590553015","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590553015?lang=en_us&edition=fundamental","pubTime":"2025-12-11 05:45","pubTimestamp":1765403105,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG14D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BXN.AU","BK7111","BK7508"],"gpt_icon":0},{"id":"2590530535","title":"Bioxyne Ltd - Unit Entered Manufacturing Agreement With Remidose Latam Srl","url":"https://stock-news.laohu8.com/highlight/detail?id=2590530535","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590530535?lang=en_us&edition=fundamental","pubTime":"2025-12-11 05:45","pubTimestamp":1765403105,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nFWN3XG14D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7111","BK7508","BXN.AU"],"gpt_icon":0},{"id":"2588088360","title":"Bioxyne Names Chief Financial Officer of Unit, Shares Fall 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588088360","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588088360?lang=en_us&edition=fundamental","pubTime":"2025-12-02 10:15","pubTimestamp":1764641752,"startTime":"0","endTime":"0","summary":"Bioxyne (ASX:BXN) appointed Paul Mitchell as the Chief Financial Officer of its wholly-owned unit, Breathe Life Sciences, according to a Tuesday Australian bourse filing.Its shares fell 5% in recent trading on Tuesday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7111","BXN.AU"],"gpt_icon":0},{"id":"2588703789","title":"Bioxyne Ltd-Bxn Strengthens Financial Leadership - Key CFO Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2588703789","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588703789?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:37","pubTimestamp":1764625021,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUE2Z3RYN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BXN.AU","BK7111","BK7508"],"gpt_icon":0},{"id":"2586110281","title":"Bioxyne Unit Ships Second GMP MDMA Batch to Victoria","url":"https://stock-news.laohu8.com/highlight/detail?id=2586110281","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586110281?lang=en_us&edition=fundamental","pubTime":"2025-11-26 10:53","pubTimestamp":1764125580,"startTime":"0","endTime":"0","summary":"Bioxyne's  Breathe Life Sciences subsidiary dispatched its second shipment of Good Manufacturing Practice  MDMA capsules to the Victorian Government's Eastern Health department, according to a Wednesday filing with the Australian bourse.The shipment will facilitate a clinical trial focused on MDMA-assisted psychotherapy for patients with co-occurring post-traumatic stress disorder and borderline personality disorder, the filing said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4095","BK7508","BXN.AU","VCCTF","BK7111"],"gpt_icon":0},{"id":"2584923751","title":"Bioxyne Executed Exclusive Import, Manufacture And Supply Agreement With Curaleaf International For Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2584923751","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584923751?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:21","pubTimestamp":1763569299,"startTime":"0","endTime":"0","summary":"Nov 3 (Reuters) - Bioxyne Ltd ::*EXECUTED EXCLUSIVE IMPORT, MANUFACTURE AND SUPPLY AGREEMENT WITH CURALEAF INTERNATIONAL FOR AUSTRALIA*TO MANUFACTURE AND DISTRIBUTE CURALEAF MEDICAL INHALATION DEVICE*","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD1PVR4V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BXN.AU","BK7111","BK7508"],"gpt_icon":0},{"id":"2584902509","title":"Bioxyne Limited's (ASX:BXN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2584902509","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584902509?lang=en_us&edition=fundamental","pubTime":"2025-11-19 07:18","pubTimestamp":1763507902,"startTime":"0","endTime":"0","summary":"Bioxyne (ASX:BXN) has had a rough three months with its share price down 32%. However, stock prices are usually driven...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5221000-choice2-main-header/1585186851278"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/household/asx-bxn/bioxyne-shares/news/bioxyne-limiteds-asxbxn-fundamentals-look-pretty-strong-coul","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/household/asx-bxn/bioxyne-shares/news/bioxyne-limiteds-asxbxn-fundamentals-look-pretty-strong-coul","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7111","BXN.AU","BK7508"],"gpt_icon":0},{"id":"2584561959","title":"Bioxyne's Unit Receives AU$1.7 Million Funding for UK Medical Cannabis Facility; Shares Fall 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584561959","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584561959?lang=en_us&edition=fundamental","pubTime":"2025-11-17 13:17","pubTimestamp":1763356667,"startTime":"0","endTime":"0","summary":"Bioxyne  said its unit Breathe Life Sciences UK has received funding of about AU$1.7 million from South of Scotland Enterprise to establish a medicinal cannabis manufacturing and distribution facility in the UK, according to a Monday filing with the Australian bourse.Application for the required licences will be completed in 2026, the filing said.Shares of the company fell 5% in recent Monday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BXN.AU","BK7508","BK7111"],"gpt_icon":0},{"id":"2582538335","title":"Bioxyne Unit Fulfills Two Purchase Orders for MDMA Capsules in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2582538335","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582538335?lang=en_us&edition=fundamental","pubTime":"2025-11-11 11:09","pubTimestamp":1762830549,"startTime":"0","endTime":"0","summary":"Bioxyne , through its Breathe Life Sciences subsidiary, fulfilled two standing purchase orders for the supply of BLSMD40 Good Manufacturing Practice-Manufactured MDMA capsules, according to a Tuesday filing with the Australian bourse.BLSMD40 is an investigational medicine designed to treat post-traumatic stress disorder supplied through Australia's Authorized Prescriber pathway for MDMA-assisted therapy, the filing said.The capsules are supplied for clinical trials in Victoria and authorized prescribers delivering psychedelic therapy-assisted services in Queensland, per the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XKO.AU","BXN.AU","XJO.AU","BK7111","XAO.AU","BK7508"],"gpt_icon":0},{"id":"2580251411","title":"Bioxyne Signs Manufacture, Supply Deal with Cannabis Company; Shares Down 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580251411","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580251411?lang=en_us&edition=fundamental","pubTime":"2025-11-03 11:15","pubTimestamp":1762139753,"startTime":"0","endTime":"0","summary":"Bioxyne , through its Breathe Life Sciences subsidiary, signed an exclusive import, manufacture, and supply agreement with Curaleaf International for the Australian market, according to a Monday filing with the Australian bourse.Breathe Life Sciences will launch Curaleaf's Que Medical Inhalation Device  in Australia this month, upon receiving import approval notification from the Therapeutic Goods Administration and authorization from the Office of Drug Control, the filing said.QMID is the first EU Class IIa medical device for use with medical cannabis liquid inhalants.The deal is expected to support the company's fiscal year 2026 revenue guidance of AU$65 million to AU$75 million and earnings before interest, taxes, depreciation, and amortization guidance of AU$11.5 million to AU$13.5 million, per the filing.Bioxyne shares fell nearly 3% in afternoon trade on Monday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7111","XKO.AU","QMID","BXN.AU","XJO.AU","XAO.AU","BK7508"],"gpt_icon":0},{"id":"2580255336","title":"BRIEF-Bioxyne Executed Exclusive Import, Manufacture And Supply Agreement With Curaleaf International For Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2580255336","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580255336?lang=en_us&edition=fundamental","pubTime":"2025-11-03 09:31","pubTimestamp":1762133477,"startTime":"0","endTime":"0","summary":"BRIEF-Bioxyne Executed Exclusive Import, Manufacture And Supply Agreement With Curaleaf International For AustraliaNov 3  - Bioxyne Ltd BXN.AX:EXECUTED EXCLUSIVE IMPORT, MANUFACTURE AND SUPPLY AGREEMENT WITH CURALEAF INTERNATIONAL FOR AUSTRALIATO MANUFACTURE AND DISTRIBUTE CURALEAF MEDICAL INHALATION DEVICEFurther company coverage: BXN.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nFWN3WE00H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7111","BK7508","BXN.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}]}}